What Happened?
Menlo Park, CA-based Adverum Appointed Michael Fitzgerald as Vice President of Human Resources
About the Company
Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet age-related macular degeneration.
About the Person
Michael Fitzgerald is Vice President of Human Resources at Adverum. Previously, Michael held various senior HR leadership roles in the industry.
Info Source
News
Short Profile